Please note: Jupiter Diagnostics is no longer trading
Jupiter Diagnostics aims to offer a faster, cheaper way to get blood test results, using a portable and easy-to-use point-of-care diagnostic reader.
Jupiter Diagnostics completed its SyndicateRoom lift round in January 2017 after raising in the region of £1,427,377.
When Jupiter Diagnostics CEO Chris Ball worked as a doctor, he discovered that an urgent blood test usually meant waiting around for hours to get a result - and this was in a busy hospital. While working at Johnson & Johnson, he saw how rapid blood glucose testing could empower patients and accelerate clinical decision-making.
However, no rapid and accurate blood testing was widely available, so he began to look for technology which could deliver high-quality affordable blood testing anywhere. The result is Jupiter Diagnostics.
Jupiter's development is based on the theory that clinic-based doctors lack ready access to reliable blood tests; currently, they must send the patient, or a blood sample, to a lab and then wait days to receive basic results. With 40 patents granted, Jupiter is looking to build a hospital lab in the palm of your hand, delivering up to eight test results in ten minutes from a single fingerprick of blood at a third of the cost. Jupiter's diagnostic reader aims to cut out unnecessary time, cost and worry for patients everywhere.
For medical professionals and patients alike, this could reduce paperwork and save time, thereby giving doctors the ability to diagnose and treat patients faster. For national health systems and insurers, this new technology has the potential to lower costs and reduce pressures resulting from waiting times and multiple patient visits. Jupiter has created a works-like/looks-like prototype and has a commercial reader under development.
Jupiter's difference is that its solution has been developed from the start with the needs of the market in mind. After assessing more than 100 different technologies against these needs, the company has sourced and combined two mature technologies to help create a robust, low-cost and easy-to-use testing hardware solution, and plans to launch its first products in 2017.
The funding from this round will be used to develop additional tests and build sales of its first products.
Where are they now?
Jupiter Diagnostics went into liquidation in March 2019.